Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-26T07:47:43.929Z Has data issue: false hasContentIssue false
  • English
  • Français

Administration of ursolic acid to new-born pups prevents dietary fructose-induced non-alcoholic fatty liver disease in Sprague Dawley rats

Published online by Cambridge University Press:  19 March 2020

Nyasha C. Mukonowenzou ,
Rachael Dangarembizi ,
Eliton Chivandi ,
Pilani Nkomozepi  and
Kennedy H. Erlwanger Open the ORCID record for Kennedy H. Erlwanger [Opens in a new window]
Nyasha C. Mukonowenzou
Affiliation:
Department of Anatomy and Physiology, Faculty of Medicine, National University of Science and Technology, Box AC 939, Ascot, Bulawayo, Zimbabwe School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, Johannesburg, 2193, South Africa
Rachael Dangarembizi
Affiliation:
Department of Anatomy and Physiology, Faculty of Medicine, National University of Science and Technology, Box AC 939, Ascot, Bulawayo, Zimbabwe School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, Johannesburg, 2193, South Africa
Eliton Chivandi
Affiliation:
School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, Johannesburg, 2193, South Africa
Pilani Nkomozepi
Affiliation:
Department of Human Anatomy and Physiology, Faculty of Health Sciences, University of Johannesburg, 37 Nind Street, Doornfontein, Johannesburg, South Africa
Kennedy H. Erlwanger*
Affiliation:
School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, Johannesburg, 2193, South Africa
*
Address for correspondence: Kennedy H. Erlwanger, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, Johannesburg, 2193, South Africa. Email: Kennedy.Erlwanger@wits.ac.za
Get access Rights & Permissions [Opens in a new window]

Abstract

Overconsumption of fructose time dependently induces the development of non-alcoholic fatty liver disease (NAFLD). We investigated whether ursolic acid (UA) intake by new-born rats would protect against fructose-induced NAFLD. One hundred and seven male and female Sprague Dawley rat pups were randomly grouped and gavaged (10 ml/kg body weight) with either 0.5% dimethylsulphoxide (vehicle control), 0.05% UA, 50% fructose mixed with UA (0.05%) or 50% fructose alone, from postnatal day 6 (P6) to P20. Post-weaning (P21–P69), the rats received normal rat chow (NRC) and water to drink. On P70, the rats in each group were continued on water or 20% fructose to drink, as a secondary high fructose diet during adulthood. After 8 weeks, body mass, food and fluid intake, circulating metabolites, visceral adiposity, surrogate markers of liver function and indices of NAFLD were determined. Food intake was reduced as a result of fructose feeding in both male and female rats (p < 0.0001). Fructose consumption in adulthood significantly increased fluid intake and visceral adiposity in female rats (p < 0.05) and had no apparent effects in male rats (p > 0.05). In both sexes of rats, fructose had no significant (p > 0.05) effects on body mass, circulating metabolites, total calorie intake and surrogate markers of hepatic function. Fructose consumption in both early life and adulthood in female rats promoted hepatic lipid accumulation (p < 0.001), hypertrophy, microvesicular and macrovesicular steatosis (p < 0.05). Early-life UA intake significantly (p < 0.001) reduced fructose-induced hepatic lipid accumulation in both male and female rats. Administration of UA during periods of developmental plasticity shows prophylactic potential against dietary fructose-induced NAFLD.

Keywords

Ursolic acidfructosenon-alcoholic fatty liver diseasedevelopmental programming
Type
Original Article
Information
Journal of Developmental Origins of Health and Disease , Volume 12 , Issue 1 , February 2021 , pp. 101 - 112
Check for updates
Copyright
© Cambridge University Press and the International Society for Developmental Origins of Health and Disease 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Deveaud, C., Beauvoit, B., Salin, B., Schaeffer, J., Rigoulet, M. Regional differences in oxidative capacity of rat white adipose tissue are linked to the mitochondrial content of mature adipocytes. Mol Cell Biochem. 2004; 267, 157–166.Google ScholarPubMed
Tappy, L, Lê, K-A. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev. 2010; 90, 23–46.CrossRefGoogle ScholarPubMed
White, JS. Sucrose, HFCS, and fructose: history, manufacture, composition, applications, and production. In Fructose, High Fructose Corn Syrup, Sucrose and Health., 2014. Springer.Google Scholar
Alberti, KGMM, Zimmet, PF. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Med. 1998; 15, 539–553.Google ScholarPubMed
Genel, S, Aurelia, C, Donca, V, Emanuela, F. Is the non-alcoholic fatty liver disease part of metabolic syndrome? J Diabetes Metab. 2015; 6, 526.Google Scholar
Jegatheesan, P, De Bandt, J-P. Fructose and NAFLD: the multifaceted aspects of fructose metabolism. Nutrients. 2017; 9, 13.Google ScholarPubMed
Alberti, K, Eckel, RH, Grundy, SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009; 120, 1640–1645.CrossRefGoogle Scholar
Marriott, BP, Cole, N, Lee, E. National estimates of dietary fructose intake increased from 1977 to 2004 in the United States. J Nutr. 2009; 139, 1228S–1235S.CrossRefGoogle ScholarPubMed
Lonardo, A., Ballestri, S., Marchesini, G., Angulo, P., Loria, P. Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome. Dig Liver Dis. 2015; 47, 181–190.CrossRefGoogle ScholarPubMed
Berg, J, Tymoczko, J, Stryer, L. The glycolytic pathway is tightly controlled. In Biochemistry. 2002. W H Freeman.Google Scholar
Basaranoglu, M, Basaranoglu, G, Bugianesi, E. Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction. Hepatobil Surg Nutr. 2015; 4, 109.Google ScholarPubMed
Basaranoglu, M, Basaranoglu, G, Bugianesi, E. Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction. Hepatobiliary Surg Nutr. 2014; 4, 109–116.Google Scholar
Softic, S, Cohen, DE, Kahn, CR. Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease. Digest Dis Sci. 2016; 61, 1282–1293.CrossRefGoogle ScholarPubMed
Li, Y-Y. Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease. World J Gastroenterol. 2012; 18, 6546–6551.CrossRefGoogle ScholarPubMed
Ziki, MDA, Mani, A. Metabolic syndrome: genetic insights into disease pathogenesis. Curr Opin Lipidol. 2016; 27, 162.Google ScholarPubMed
Kunes, J, Vaneckova, I, Mikulaskova, B, Behuliak, M, Maletínská, L, Zicha, J. Epigenetics and a new look on metabolic syndrome. Physiol Res. 2015; 64, 611.CrossRefGoogle Scholar
Lee, JH, Friso, S, Choi, S-W. Epigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutrition. Nutrients. 2014; 6, 3303–3325.CrossRefGoogle ScholarPubMed
Marciniak, A, Patro-Małysza, J, Kimber-Trojnar, Ż, Marciniak, B, Oleszczuk, J, Leszczyńska-Gorzelak, B. Fetal programming of the metabolic syndrome. Taiwan J Obstet Gynecol. 2017; 56, 133–138.CrossRefGoogle ScholarPubMed
Wesolowski, SR, Kasmi, KCE, Jonscher, KR, Friedman, JE. Developmental origins of NAFLD: a womb with a clue. Nat Rev Gastroenterol Hepatol. 2017; 14, 81–96.Google ScholarPubMed
Kochhar, S, Martin, FP. Metabonomics and Gut Microbiota in Nutrition and Disease, 2014. Springer, London.Google Scholar
Lillycrop, KA, Burdge, GC. Epigenetic changes in early life and future risk of obesity. Int J Obes. 2011; 35, 72–83.CrossRefGoogle ScholarPubMed
Li, M, Reynolds, CM, Segovia, SA, Gray, C, Vickers, MH. Developmental programming of nonalcoholic fatty liver disease: the effect of early life nutrition on susceptibility and disease severity in later life. Biomed Res Int. 2015b; 2015.Google ScholarPubMed
Vickers, MH. Developmental programming of the metabolic syndrome-critical windows for intervention. World J Diab. 2011; 2, 137–148.CrossRefGoogle ScholarPubMed
Wesolowski, SR, El Kasmi, KC, Jonscher, KR, Friedman, JE. 2016. Developmental origins of NAFLD: a womb with a clue. Nat Rev Gastroenterol Hepatol.Google Scholar
Buzzetti, E, Pinzani, M, Tsochatzis, EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016; 65, 1038–1048.CrossRefGoogle Scholar
Heindel, JJ, Balbus, J, Birnbaum, L, et al. Developmental origins of health and disease: integrating environmental influences. Endocrinology. 2015; 156, 3416–3421.CrossRefGoogle Scholar
Soderborg, TK, Clark, SE, Mulligan, CE, et al. The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD. Nat Commun. 2018; 9, 1–12.CrossRefGoogle ScholarPubMed
Treviño, LS, Katz, TA. Endocrine disruptors and developmental origins of nonalcoholic fatty liver disease. Endocrinology. 2018; 159, 20–31.CrossRefGoogle ScholarPubMed
de Lorgeril, M. Commentary on the clinical management of metabolic syndrome: why a healthy lifestyle is important. BMC Med. 2012; 10, 139.CrossRefGoogle Scholar
Rubio-Ruiz, M, Hafidi, ME, Perez-Torres, I, Banos, G, Guarner, V. Medicinal agents and metabolic syndrome. Curr Med Chem. 2013; 20, 2626–2640.Google ScholarPubMed
Michos, ED, Sibley, CT, Baer, JT, Blaha, MJ, Blumenthal, RS. Niacin and statin combination therapy for atherosclerosis regression and prevention of cardiovascular disease events: reconciling the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) trial with previous surrogate endpoint trials. J Am Coll Cardiol. 2012; 59, 2058–2064.CrossRefGoogle ScholarPubMed
Song, R Mechanism of metformin: a tale of two sites. Diabetes Care. 2016; 39, 187–189.CrossRefGoogle ScholarPubMed
Kaur, J. A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014; 2014.Google ScholarPubMed
Marvasti, BT, Adeli, KH. Pharmacological management of metabolic syndrome and its lipid complications. Daru. 2010; 18, 146.Google Scholar
Johnson, PH. Global use of complementary and integrative health approches. In: HOLTZ, C. (ed.) Global Health Care: Issues and Policies 3ed., 2016 Burlington, United States of America: Jones & Bartlett Learning.Google Scholar
Payyappallimana, U. Role of traditional medicine in primary health care: an overview of perspectives and challenging, 2010.Google Scholar
WHO 2014. WHO Traditional Medicine Strategy 2014–2023. Geneva; 2013.Google Scholar
Li, S, Meng, F, Liao, X, et al. Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats. PLoS One. 2014; 9, e86724.CrossRefGoogle ScholarPubMed
Nyakudya, T, Mukwevho, E, Nkomozepi, P, Erlwanger, K. Neonatal intake of oleanolic acid attenuates the subsequent development of high fructose diet-induced non-alcoholic fatty liver disease in rats. J Dev Orig Health Dis. 2018; 9, 500–510.CrossRefGoogle ScholarPubMed
Prabhakar, P, Reeta, K, Maulik, SK, Dinda, AK, Gupta, YK. α-Amyrin attenuates high fructose diet-induced metabolic syndrome in rats. Appl Physiol Nutr Metab. 2016; 42, 23–32.CrossRefGoogle ScholarPubMed
He, X, Liu, RH. Triterpenoids isolated from apple peels have potent antiproliferative activity and may be partially responsible for apple’s anticancer activity. J Agr Food Chem. 2007; 55, 4366–4370.CrossRefGoogle ScholarPubMed
Le Men, J, Pourrat, H. The presence of ursolic acid in the leaves of Vinca minor L., Nerium oleander L. and Salvia officinalis L . Annales Pharmaceutiques Francaises. 1952; 349–351.Google ScholarPubMed
Ismaili, H, Tortora, S, Sosa, S, et al. Topical anti-inflammatory activity of Thymus willdenowii. J Pharm Pharmacol. 2001; 53, 1645–1652.Google ScholarPubMed
Kang, W, Song, Y, Gu, X. α-glucosidase inhibitory in vitro and antidiabetic activity in vivo of Osmanthus fragrans. J Med Plants Res. 2012; 6, 2850–2856.Google Scholar
Li, Y, Kang, Z, Li, S, Kong, T, Liu, X, Sun, C. Ursolic acid stimulates lipolysis in primary-cultured rat adipocytes. Mol Nutr Food Res. 2010; 54, 1609–1617.CrossRefGoogle ScholarPubMed
Li, J-S, Wang, W-J, Sun, Y, Zhang, Y-H, Zheng, L. Ursolic acid inhibits the development of nonalcoholic fatty liver disease by attenuating endoplasmic reticulum stress. Food Funct. 2015a; 6, 1643–1651.CrossRefGoogle ScholarPubMed
Kim, S-H, Ryu, HG, Lee, J, et al. Ursolic acid exerts anti-cancer activity by suppressing vaccinia-related kinase 1-mediated damage repair in lung cancer cells. Sci Rep. 2015; 5.Google ScholarPubMed
Gluckman, PD, Hanson, MA. The developmental origins of the metabolic syndrome. Trends Endocrin Met. 2004; 15, 183–187.Google ScholarPubMed
Langley-Evans, SC. Developmental programming of health and disease. Proc Nutr Soc. 2006; 65, 97–105.CrossRefGoogle ScholarPubMed
Monaghan, P, Haussmann, MF. The positive and negative consequences of stressors during early life. Early Hum Dev. 2015; 91, 643–647.CrossRefGoogle ScholarPubMed
Beigh, SH, Jain, S. Prevalence of metabolic syndrome and gender differences. Bioinformation. 2012; 8, 613–616.CrossRefGoogle ScholarPubMed
Tsai, Y-J, Wu, M-P, Hsu, Y-W. Emerging health problems among women: Inactivity, obesity, and metabolic syndrome. Gynecol Minim Invasive Ther. 2014; 3, 12–14.Google Scholar
Korićanac, G., Đorđević, A., Žakula, Z., et al. Gender modulates development of the metabolic syndrome phenotype in fructose-fed rats. Arch Biol Sci. 2013; 65, 455–464.CrossRefGoogle Scholar
Crescenzo, R, Cigliano, L, Mazzoli, A, et al. Early effects of a low fat, fructose-rich diet on liver metabolism, insulin signaling, and oxidative stress in young and adult rats. Front Physiol. 2018; 9, 411.CrossRefGoogle Scholar
Sundaresan, A, Harini, R, Viswanathan, P. Ursolic acid and rosiglitazone combination alleviates metabolic syndrome in high fat diet fed C57BL/6J mice. Gen Physiol Biophys. 2012; 31, 323.CrossRefGoogle ScholarPubMed
Rao, VS, De Melo, CL, Queiroz, MGR, et al. Ursolic acid, a pentacyclic triterpene from Sambucus australis, prevents abdominal adiposity in mice fed a high-fat diet. J Med Food. 2011; 14, 1375–1382.CrossRefGoogle ScholarPubMed
Suliga, E, Kozieł, D, Cieśla, E, Rębak, D, Głuszek, S. Dietary patterns in relation to metabolic syndrome among adults in Poland: a cross-sectional study. Nutrients. 2017; 9, 1366.CrossRefGoogle ScholarPubMed
Sengupta, P. The laboratory rat: relating its age with human’s. Int J Prev Med. 2013; 4, 624.Google ScholarPubMed
Mamikutty, N, Thent, ZC, Sapri, SR, Sahruddin, NN, Mohd Yusof, MR, Haji Suhaimi, F. The establishment of metabolic syndrome model by induction of fructose drinking water in male Wistar rats. BioMed Res Int. 2014.Google Scholar
Parasuraman, S, Raveendran, R, Kesavan, R. Blood sample collection in small laboratory animals. J Pharmacol Pharmacother. 2010; 1, 87.CrossRefGoogle ScholarPubMed
Bancroft, JD, Gamble, M. Theory and Practice of Histological Techniques, 2008. Elsevier Health Sciences.Google Scholar
Liang, W, Menke, AL, Driessen, A, et al. Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology. PloS one. 2014; 9, e115922.Google ScholarPubMed
Äijälä, M, Malo, E, Ukkola, O, et al. Long-term fructose feeding changes the expression of leptin receptors and autophagy genes in the adipose tissue and liver of male rats: a possible link to elevated triglycerides. Genes Nutr. 2013; 8, 623–635.CrossRefGoogle ScholarPubMed
Lindqvist, A, Baelemans, A, Erlanson-Albertsson, C. Effects of sucrose, glucose and fructose on peripheral and central appetite signals. Regul Pept. 2008; 150, 26–32.CrossRefGoogle ScholarPubMed
Barros, CMM, Lessa, RQ, Grechi, MP, et al. Substitution of drinking water by fructose solution induces hyperinsulinemia and hyperglycemia in hamsters. Clinics. 2007; 62, 327–334.CrossRefGoogle ScholarPubMed
Mamikutty, N, Thent, ZC, Haji Suhaimi, F. Fructose-drinking water induced nonalcoholic fatty liver disease and ultrastructural alteration of hepatocyte mitochondria in Male wistar rat. Biomed Res Int. 2015.Google Scholar
Stanhope, KL, Bremer, AA, Medici, V, et al. Consumption of fructose and high fructose corn syrup increase postprandial triglycerides, LDL-cholesterol, and apolipoprotein-B in young men and women. J Clin Endocrinol Metab,. 2011; 96, E1596–E1605.Google ScholarPubMed
Seneff, S, Wainwright, G, Mascitelli, L. Is the metabolic syndrome caused by a high fructose, and relatively low fat, low cholesterol diet? Arch Med Sci. 2011; 7, 8.CrossRefGoogle ScholarPubMed
Jameel, F, Phang, M, Wood, LG, Garg, ML. Acute effects of feeding fructose, glucose and sucrose on blood lipid levels and systemic inflammation. Lipids Health Dis. 2014; 13, 195.CrossRefGoogle ScholarPubMed
Shen, M, Shi, H. Sex hormones and their receptors regulate liver energy homeostasis. Int J Endocrinol Metab. 2015; 2015.Google ScholarPubMed
Tara, M, Souza, SC, Aronovitz, M, Obin, MS, Fried, SK, Greenberg, AS. Estrogen regulation of adiposity and fuel partitioning evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem. 2005; 280, 35983–35991.Google Scholar
Wang, X, Li, L, Wang, B, Xiang, J. Effects of ursolic acid on the proliferation and apoptosis of human ovarian cancer cells. J Huazhong Univ Sci Technol Med Sci. 2009; 29, 761–764.CrossRefGoogle ScholarPubMed
Yuliang, W, Zejian, W, Hanlin, S, Ming, Y, Kexuan, T. The hypolipidemic effect of artesunate and ursolic acid in rats. Pak J Pharm Sci. 2015; 28.Google ScholarPubMed
Dinicolantonio, JJ, Mehta, V, Onkaramurthy, N, O’keefe, JH. Fructose-induced inflammation and increased cortisol: a new mechanism for how sugar induces visceral adiposity. Prog Cardiovasc Dis. 2017; 61(1).Google ScholarPubMed
Kovačević, S, Nestorov, J, Matić, G, Elaković, I. Fructose-enriched diet induces inflammation and reduces antioxidative defense in visceral adipose tissue of young female rats. Eur J Nutr. 2017; 56, 151–160.CrossRefGoogle ScholarPubMed
Softic, S, Gupta, MK, Wang, G-X, et al. Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling. J Clin Invest. 2018; 128, 1199–1199.CrossRefGoogle ScholarPubMed
Browning, JD, Szczepaniak, LS, Dobbins, R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004; 40, 1387–1395.CrossRefGoogle Scholar
Cai, D, Yuan, M, Frantz, DF, et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB. Nat Med. 2005; 11, 183.CrossRefGoogle ScholarPubMed
Poeta, M, Pierri, L, Vajro, P. Gut–liver axis derangement in non-alcoholic fatty liver disease. Children. 2017; 4, 66.CrossRefGoogle ScholarPubMed
Jensen, T, Abdelmalek, MF, Sullivan, S, et al. Fructose and sugar: a major mediator of non-alcoholic fatty liver disease. J Hepatol. 2018; 68, 1063–1075.CrossRefGoogle Scholar
Crescenzo, R, Bianco, F, Falcone, I, Coppola, P, Liverini, G, Iossa, S. Increased hepatic de novo lipogenesis and mitochondrial efficiency in a model of obesity induced by diets rich in fructose. Eur J Nutr. 2013; 52, 537–545.Google Scholar
Baena, M, Sangüesa, G, Hutter, N, et al. Fructose supplementation impairs rat liver autophagy through mTORC activation without inducing endoplasmic reticulum stress. Biochim Biophys Acta. 2015; 1851, 107–116.CrossRefGoogle ScholarPubMed
Choi, Y, Abdelmegeed, MA, Song, B-J. Diet high in fructose promotes liver steatosis and hepatocyte apoptosis in C57BL/6J female mice: Role of disturbed lipid homeostasis and increased oxidative stress. Food Chem Toxicol. 2017; 103, 111–121.CrossRefGoogle ScholarPubMed
Mofrad, P, Contos, MJ, Haque, M, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology. 2003; 37, 1286–1292.CrossRefGoogle ScholarPubMed
Verma, S, Jensen, D, Hart, J, Mohanty, SR. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD). Liver Int. 2013; 33, 1398–1405.CrossRefGoogle Scholar
Jia, Y, Bhuiyan, MJH, Jun, H-J, et al. Ursolic acid is a PPAR-α agonist that regulates hepatic lipid metabolism. Bioorg Med Chem. 2011; 21, 5876–5880.Google ScholarPubMed
Jia, Y, Kim, S, Kim, J, et al. Ursolic acid improves lipid and glucose metabolism in high-fat-fed C57BL/6J mice by activating peroxisome proliferator-activated receptor alpha and hepatic autophagy. Mol Nutr Food Res. 2015; 59, 344–354.Google ScholarPubMed
Singh, R, Kaushik, S, Wang, Y, et al. Autophagy regulates lipid metabolism. Nature. 2009; 458, 1131.CrossRefGoogle ScholarPubMed
Keating, GM. Fenofibrate. Am J Cardiovasc Drug. 2011; 11, 227–247.Google ScholarPubMed
Marks, KA, Kitson, AP, Stark, KD. Hepatic and plasma sex differences in saturated and monounsaturated fatty acids are associated with differences in expression of elongase 6, but not stearoyl-CoA desaturase in Sprague–Dawley rats. Genes Nutr. 2013; 8, 317.CrossRefGoogle Scholar
Supplementary material: File

Mukonowenzou et al. supplementary material

Mukonowenzou et al. supplementary material

Download Mukonowenzou et al. supplementary material(File)
File 34.7 KB